Literature DB >> 313367

Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection.

L K Cauley, J W Murphy.   

Abstract

A Cryptococcus neoformans infection in congenitally athymic (nude) mice and phenotypically normal heterozygote BALB/c mice was used to determine how T lymphocyte-deficient mice compared with normal mice in restricting proliferation of C. neoformans and to determine whether a correlation exists between delayed-type hypersensitivity and resistance to C. neoformans. Although nude mice displayed the ability to maintain cryptococcal population levels lower than did the phenotypically normal animals during the first 14 days of infection, the resistance was not sufficient to control the infection during the remainder of the 35-day experimental period. Heterozygote mice began to demonstrate positive delayed-type hypersensitivity responses by day 14 postinfection; however, nude mice were unable to mount delayed-type hypersensitivity responses. The appearance of the delayed-type hypersensitivity response in the heterozygote mice was concomitant with the reduced rate of proliferation of C. neoformans observed in those animals from days 14 to 35. Because anticryptococcal antibody titers and cryptococcal antigen levels were equivalent in both groups of mice, T-lymphocyte function was considered to be responsible for the resistance observed in the heterozygote mice. The mechanism by which cryptococcal populations were reduced was not addressed; however, the mouse model system used in these studies would be an ideal tool for studying those mechanisms. Nude mice were able to produce antibodies against cryptococcal cells, indicating that at least one component of C. neoformans is a T-independent antigen. The antibody response was predominantly immunoglobulin M in nude and heterozygote mice. Cryptococcal antigen levels were extremely high in both groups of animals and appeared to increase as C. neoformans cell numbers increased.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 313367      PMCID: PMC414213          DOI: 10.1128/iai.23.3.644-651.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  EXPERIMENTAL CRYPTOCOCCOSIS: HYPERSENSITIVITY AND IMMUNITY.

Authors:  A K PERCEVAL
Journal:  J Pathol Bacteriol       Date:  1965-04

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Role of activated macrophages in resistance of congenitally athymic nude mice to hepatitis induced by herpes simplex virus type 2.

Authors:  S C Mogensen; H K Andersen
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

4.  The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis.

Authors:  T J Rogers; E Balish; D D Manning
Journal:  J Reticuloendothel Soc       Date:  1976-10

5.  Effects of stimulation and suppression of cell-mediated immunity on experimental cryptococcosis.

Authors:  R D Diamond
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

6.  Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans.

Authors:  R D Diamond; A C Allison
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

7.  Host defense in cryptococcosis. I. An in vivo model for evaluating immune response.

Authors:  J R Graybill; R L Taylor
Journal:  Int Arch Allergy Appl Immunol       Date:  1978

8.  Effect of antilymphocyte serum on animals experimentally infected with Histoplasma capsulatum or Cryptococcus neoformans.

Authors:  D M Adamson; G C Cozad
Journal:  J Bacteriol       Date:  1969-12       Impact factor: 3.490

9.  Significance of T cells in resistance to experimental murine coccidioidomycosis.

Authors:  L Beaman; D Pappagianis; E Benjamini
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

10.  Anomalous high native resistance to athymic mice to bacterial pathogens.

Authors:  A D Nickol; P F Bonventre
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

View more
  72 in total

1.  Effects of cyclosporin A on the cells responsible for the anticryptococcal cell-mediated immune response and its regulation.

Authors:  P L Fidel; J W Murphy
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

2.  Requirement for CD4(+) T lymphocytes in host resistance against Cryptococcus neoformans in the central nervous system of immunized mice.

Authors:  K L Buchanan; H A Doyle
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Systemic Coccidioides immitis infection in nude and beige mice.

Authors:  K V Clemons; C R Leathers; K W Lee
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

4.  Effects of cyclosporine in experimental cryptococcal meningitis.

Authors:  J R Perfect; D T Durack
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

5.  In vitro interactions of immune lymphocytes and Cryptococcus neoformans.

Authors:  P Y Fung; J W Murphy
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

Review 6.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

7.  Immunogenic fractions of Cryptococcus neoformans.

Authors:  J R Graybill; D C Straus; T J Nealon; M Hague; R E Paque
Journal:  Mycopathologia       Date:  1982-04-23       Impact factor: 2.574

8.  Genetic study of oxygen resistance and melanization in Cryptococcus neoformans.

Authors:  H S Emery; C P Shelburne; J P Bowman; P G Fallon; C A Schulz; E S Jacobson
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Anticryptococcal resistance in the mouse brain: beneficial effects of local administration of heat-inactivated yeast cells.

Authors:  E Blasi; R Mazzolla; R Barluzzi; P Mosci; F Bistoni
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  Host defense in Cryptococcosis. III. In vivo alteration of immunity.

Authors:  J R Graybill; L Mitchell
Journal:  Mycopathologia       Date:  1979-12-28       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.